Sustained intra-cartilage delivery of low dose dexamethasone using a cationic carrier for treatment of post traumatic osteoarthritis
Disease-modifying osteoarthritis drugs (DMOADs) should reach their intra-tissue target sites at optimal doses for clinical efficacy. The dense, negatively charged matrix of cartilage poses a major hindrance to the transport of potential therapeutics. In this work, electrostatic interactions were uti...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
ECM Research Journal
2018
|
| Online Access: | http://hdl.handle.net/1721.1/117741 https://orcid.org/0000-0003-4750-7207 https://orcid.org/0000-0001-7880-1391 https://orcid.org/0000-0002-4942-3456 |
| _version_ | 1826214204369010688 |
|---|---|
| author | De la Vega, RE Scheu, M Brown, LA Fitzsimons, TJ Porter, RM Bajpayee, Ambika Goel Varady, Nathan H. Yannatos, I. A. Krishnan, Yamini Bhattacharya, Paulomi Frank, Eliot Henry Grodzinsky, Alan J Porter, R. M. |
| author2 | Massachusetts Institute of Technology. Center for Biomedical Engineering |
| author_facet | Massachusetts Institute of Technology. Center for Biomedical Engineering De la Vega, RE Scheu, M Brown, LA Fitzsimons, TJ Porter, RM Bajpayee, Ambika Goel Varady, Nathan H. Yannatos, I. A. Krishnan, Yamini Bhattacharya, Paulomi Frank, Eliot Henry Grodzinsky, Alan J Porter, R. M. |
| author_sort | De la Vega, RE |
| collection | MIT |
| description | Disease-modifying osteoarthritis drugs (DMOADs) should reach their intra-tissue target sites at optimal doses for clinical efficacy. The dense, negatively charged matrix of cartilage poses a major hindrance to the transport of potential therapeutics. In this work, electrostatic interactions were utilised to overcome this challenge and enable higher uptake, full-thickness penetration and enhanced retention of dexamethasone (Dex) inside rabbit cartilage. This was accomplished by using the positively charged glycoprotein avidin as nanocarrier, conjugated to Dex by releasable linkers. Therapeutic effects of a single intra-articular injection of low dose avidin-Dex (0.5 mg Dex) were evaluated in rabbits 3 weeks after anterior cruciate ligament transection (ACLT). Immunostaining confirmed that avidin penetrated the full cartilage thickness and was retained for at least 3 weeks. Avidin-Dex suppressed injury-induced joint swelling and catabolic gene expression to a greater extent than free Dex. It also significantly improved the histological score of cell infiltration and morphogenesis within the periarticular synovium. Micro-computed tomography confirmed the reduced incidence and volume of osteophytes following avidin-Dex treatment. However, neither treatment restored the loss of cartilage stiffness following ACLT, suggesting the need for a combinational therapy with a pro-anabolic factor for enhancing matrix biosynthesis. The avidin dose used caused significant glycosaminoglycan (GAG) loss, suggesting the use of higher Dex : avidin ratios in future formulations, such that the delivered avidin dose could be much
less than that shown to affect GAGs. This charge-based delivery system converted cartilage into a drug depot that could also be employed for delivery to nearby synovium, menisci and ligaments, enabling clinical
translation of a variety of DMOADs. |
| first_indexed | 2024-09-23T16:01:46Z |
| format | Article |
| id | mit-1721.1/117741 |
| institution | Massachusetts Institute of Technology |
| last_indexed | 2024-09-23T16:01:46Z |
| publishDate | 2018 |
| publisher | ECM Research Journal |
| record_format | dspace |
| spelling | mit-1721.1/1177412022-10-02T05:48:58Z Sustained intra-cartilage delivery of low dose dexamethasone using a cationic carrier for treatment of post traumatic osteoarthritis De la Vega, RE Scheu, M Brown, LA Fitzsimons, TJ Porter, RM Bajpayee, Ambika Goel Varady, Nathan H. Yannatos, I. A. Krishnan, Yamini Bhattacharya, Paulomi Frank, Eliot Henry Grodzinsky, Alan J Porter, R. M. Massachusetts Institute of Technology. Center for Biomedical Engineering Massachusetts Institute of Technology. Department of Biological Engineering Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science Massachusetts Institute of Technology. Department of Mechanical Engineering Bajpayee, Ambika Goel Varady, Nathan H. Yannatos, I. A. Krishnan, Yamini Bhattacharya, Paulomi Frank, Eliot Henry Grodzinsky, Alan J Porter, R. M. Disease-modifying osteoarthritis drugs (DMOADs) should reach their intra-tissue target sites at optimal doses for clinical efficacy. The dense, negatively charged matrix of cartilage poses a major hindrance to the transport of potential therapeutics. In this work, electrostatic interactions were utilised to overcome this challenge and enable higher uptake, full-thickness penetration and enhanced retention of dexamethasone (Dex) inside rabbit cartilage. This was accomplished by using the positively charged glycoprotein avidin as nanocarrier, conjugated to Dex by releasable linkers. Therapeutic effects of a single intra-articular injection of low dose avidin-Dex (0.5 mg Dex) were evaluated in rabbits 3 weeks after anterior cruciate ligament transection (ACLT). Immunostaining confirmed that avidin penetrated the full cartilage thickness and was retained for at least 3 weeks. Avidin-Dex suppressed injury-induced joint swelling and catabolic gene expression to a greater extent than free Dex. It also significantly improved the histological score of cell infiltration and morphogenesis within the periarticular synovium. Micro-computed tomography confirmed the reduced incidence and volume of osteophytes following avidin-Dex treatment. However, neither treatment restored the loss of cartilage stiffness following ACLT, suggesting the need for a combinational therapy with a pro-anabolic factor for enhancing matrix biosynthesis. The avidin dose used caused significant glycosaminoglycan (GAG) loss, suggesting the use of higher Dex : avidin ratios in future formulations, such that the delivered avidin dose could be much less than that shown to affect GAGs. This charge-based delivery system converted cartilage into a drug depot that could also be employed for delivery to nearby synovium, menisci and ligaments, enabling clinical translation of a variety of DMOADs. National Science Foundation (U.S.) (Grant DMR1419807) National Institutes of Health (U.S.) (Grant EB017755) National Institute of Biomedical Imaging and Bioengineering (U.S.) (Grant EB017755) National Institutes of Health (U.S.) (Grant AR057105) National Institutes of Health (U.S.) (Grant AR060331) National Institute of Arthritis and Musculoskeletal and Skin Diseases (U.S.) (Grant AR057105) National Institute of Arthritis and Musculoskeletal and Skin Diseases (U.S.) (Grant (Grant AR060331) 2018-09-13T15:58:32Z 2018-09-13T15:58:32Z 2017-12 2018-09-06T16:13:20Z Article http://purl.org/eprint/type/JournalArticle 1473-2262 http://hdl.handle.net/1721.1/117741 Bajpayee, AG et al. “Sustained Intra-Cartilage Delivery of Low Dose Dexamethasone Using a Cationic Carrier for Treatment of Post Traumatic Osteoarthritis.” European Cells and Materials 34 (December 2017): 341–364 https://orcid.org/0000-0003-4750-7207 https://orcid.org/0000-0001-7880-1391 https://orcid.org/0000-0002-4942-3456 http://www.ecmjournal.org/papers/vol034/vol034a21.php European Cells and Materials Creative Commons Attribution-Noncommercial-Share Alike http://creativecommons.org/licenses/by-nc-sa/4.0/ application/pdf ECM Research Journal European Cells and Materials |
| spellingShingle | De la Vega, RE Scheu, M Brown, LA Fitzsimons, TJ Porter, RM Bajpayee, Ambika Goel Varady, Nathan H. Yannatos, I. A. Krishnan, Yamini Bhattacharya, Paulomi Frank, Eliot Henry Grodzinsky, Alan J Porter, R. M. Sustained intra-cartilage delivery of low dose dexamethasone using a cationic carrier for treatment of post traumatic osteoarthritis |
| title | Sustained intra-cartilage delivery of low dose dexamethasone using a cationic carrier for treatment of post traumatic osteoarthritis |
| title_full | Sustained intra-cartilage delivery of low dose dexamethasone using a cationic carrier for treatment of post traumatic osteoarthritis |
| title_fullStr | Sustained intra-cartilage delivery of low dose dexamethasone using a cationic carrier for treatment of post traumatic osteoarthritis |
| title_full_unstemmed | Sustained intra-cartilage delivery of low dose dexamethasone using a cationic carrier for treatment of post traumatic osteoarthritis |
| title_short | Sustained intra-cartilage delivery of low dose dexamethasone using a cationic carrier for treatment of post traumatic osteoarthritis |
| title_sort | sustained intra cartilage delivery of low dose dexamethasone using a cationic carrier for treatment of post traumatic osteoarthritis |
| url | http://hdl.handle.net/1721.1/117741 https://orcid.org/0000-0003-4750-7207 https://orcid.org/0000-0001-7880-1391 https://orcid.org/0000-0002-4942-3456 |
| work_keys_str_mv | AT delavegare sustainedintracartilagedeliveryoflowdosedexamethasoneusingacationiccarrierfortreatmentofposttraumaticosteoarthritis AT scheum sustainedintracartilagedeliveryoflowdosedexamethasoneusingacationiccarrierfortreatmentofposttraumaticosteoarthritis AT brownla sustainedintracartilagedeliveryoflowdosedexamethasoneusingacationiccarrierfortreatmentofposttraumaticosteoarthritis AT fitzsimonstj sustainedintracartilagedeliveryoflowdosedexamethasoneusingacationiccarrierfortreatmentofposttraumaticosteoarthritis AT porterrm sustainedintracartilagedeliveryoflowdosedexamethasoneusingacationiccarrierfortreatmentofposttraumaticosteoarthritis AT bajpayeeambikagoel sustainedintracartilagedeliveryoflowdosedexamethasoneusingacationiccarrierfortreatmentofposttraumaticosteoarthritis AT varadynathanh sustainedintracartilagedeliveryoflowdosedexamethasoneusingacationiccarrierfortreatmentofposttraumaticosteoarthritis AT yannatosia sustainedintracartilagedeliveryoflowdosedexamethasoneusingacationiccarrierfortreatmentofposttraumaticosteoarthritis AT krishnanyamini sustainedintracartilagedeliveryoflowdosedexamethasoneusingacationiccarrierfortreatmentofposttraumaticosteoarthritis AT bhattacharyapaulomi sustainedintracartilagedeliveryoflowdosedexamethasoneusingacationiccarrierfortreatmentofposttraumaticosteoarthritis AT frankeliothenry sustainedintracartilagedeliveryoflowdosedexamethasoneusingacationiccarrierfortreatmentofposttraumaticosteoarthritis AT grodzinskyalanj sustainedintracartilagedeliveryoflowdosedexamethasoneusingacationiccarrierfortreatmentofposttraumaticosteoarthritis AT porterrm sustainedintracartilagedeliveryoflowdosedexamethasoneusingacationiccarrierfortreatmentofposttraumaticosteoarthritis |